Literature DB >> 33692194

Original Antigenic Sin: the Downside of Immunological Memory and Implications for COVID-19.

Eric L Brown1, Heather T Essigmann2.   

Abstract

The concept of original antigenic sin (OAS) was put forth many years ago to explain how humoral memory responses generated against one set of antigens can affect the nature of antibody responses elicited to challenge infections or vaccinations containing a similar but not identical array of antigens. Here, we highlight the link between OAS and the germinal center reaction (GCR), a process unique to activated B cells undergoing somatic hypermutation and class switch recombination. It is the powerful response of activated memory B cells and the accompanying GCR that establish the foundations of OAS. We apply these concepts to the current COVID-19 pandemic and put forth several possible scenarios whereby OAS may result in either beneficial or harmful outcomes depending, hypothetically, on prior exposure to antigens shared between SARS-CoV-2 and seasonal human coronaviruses (hCoVs) that include betacoronaviruses (e.g., HCoV-OC43 and HCoV-HKU1) and alphacoronaviruses (e.g., HCoV-NL63 and HCoV-HKU1) (E. M. Anderson, E. C. Goodwin, A. Verma, C. P. Arevalo, et al., medRxiv, 2020, https://doi.org/10.1101/2020.11.06.20227215; S. M. Kissler, C. Tedijanto, E. Goldstein, Y. H. Grad, and M. Lipsitch, Science 368:860-868, 2020, https://doi.org/10.1126/science.abb5793).
Copyright © 2021 Brown and Essigmann.

Entities:  

Keywords:  B cells; COVID-19; affinity maturation; germinal center; germinal center reaction; humoral immunity; immunity; imprinting; memory responses; original antigenic sin; vaccines

Mesh:

Substances:

Year:  2021        PMID: 33692194     DOI: 10.1128/mSphere.00056-21

Source DB:  PubMed          Journal:  mSphere        ISSN: 2379-5042            Impact factor:   4.389


  11 in total

Review 1.  Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations.

Authors:  Lily E Cohen; David J Spiro; Cecile Viboud
Journal:  PLoS Pathog       Date:  2022-06-30       Impact factor: 7.464

Review 2.  Know your enemy or find your friend?-Induction of IgA at mucosal surfaces.

Authors:  Mats Bemark; Davide Angeletti
Journal:  Immunol Rev       Date:  2021-07-30       Impact factor: 10.983

3.  The impact of the Th17:Treg axis on the IgA-Biome across the glycemic spectrum.

Authors:  Heather T Essigmann; Kristi L Hoffman; Joseph F Petrosino; Goo Jun; David Aguilar; Craig L Hanis; Herbert L DuPont; Eric L Brown
Journal:  PLoS One       Date:  2021-10-20       Impact factor: 3.240

4.  Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.

Authors:  Min-Wen Ku; Pierre Authié; Maryline Bourgine; François Anna; Amandine Noirat; Fanny Moncoq; Benjamin Vesin; Fabien Nevo; Jodie Lopez; Philippe Souque; Catherine Blanc; Ingrid Fert; Sébastien Chardenoux; Llta Lafosse; Delphine Cussigh; David Hardy; Kirill Nemirov; Françoise Guinet; Francina Langa Vives; Laleh Majlessi; Pierre Charneau
Journal:  EMBO Mol Med       Date:  2021-10-25       Impact factor: 12.137

5.  Allelic variation in class I HLA determines CD8+ T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2.

Authors:  Joshua M Francis; Del Leistritz-Edwards; Augustine Dunn; Christina Tarr; Jesse Lehman; Conor Dempsey; Andrew Hamel; Violeta Rayon; Gang Liu; Yuntong Wang; Marcos Wille; Melissa Durkin; Kane Hadley; Aswathy Sheena; Benjamin Roscoe; Mark Ng; Graham Rockwell; Margaret Manto; Elizabeth Gienger; Joshua Nickerson; Amir Moarefi; Michael Noble; Thomas Malia; Philip D Bardwell; William Gordon; Joanna Swain; Mojca Skoberne; Karsten Sauer; Tim Harris; Ananda W Goldrath; Alex K Shalek; Anthony J Coyle; Christophe Benoist; Daniel C Pregibon
Journal:  Sci Immunol       Date:  2022-01-21

6.  Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs.

Authors:  Meriem Bekliz; Kenneth Adea; Pauline Vetter; Christiane S Eberhardt; Krisztina Hosszu-Fellous; Diem-Lan Vu; Olha Puhach; Manel Essaidi-Laziosi; Sophie Waldvogel-Abramowski; Caroline Stephan; Arnaud G L'Huillier; Claire-Anne Siegrist; Arnaud M Didierlaurent; Laurent Kaiser; Benjamin Meyer; Isabella Eckerle
Journal:  Nat Commun       Date:  2022-07-04       Impact factor: 17.694

7.  Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses.

Authors:  Anna L McNaughton; Robert S Paton; Matthew Edmans; Jonathan Youngs; Judith Wellens; Prabhjeet Phalora; Alex Fyfe; Sandra Belij-Rammerstorfer; Jai S Bolton; Jonathan Ball; George W Carnell; Wanwisa Dejnirattisai; Christina Dold; David W Eyre; Philip Hopkins; Alison Howarth; Kreepa Kooblall; Hannah Klim; Susannah Leaver; Lian Ni Lee; César López-Camacho; Sheila F Lumley; Derek C Macallan; Alexander J Mentzer; Nicholas M Provine; Jeremy Ratcliff; Jose Slon-Compos; Donal Skelly; Lucas Stolle; Piyada Supasa; Nigel Temperton; Chris Walker; Beibei Wang; Duncan Wyncoll; Peter Simmonds; Teresa Lambe; John Kenneth Baillie; Malcolm G Semple; Peter Jm Openshaw; Uri Obolski; Marc Turner; Miles Carroll; Juthathip Mongkolsapaya; Gavin Screaton; Stephen H Kennedy; Lisa Jarvis; Eleanor Barnes; Susanna Dunachie; José Lourenço; Philippa C Matthews; Tihana Bicanic; Paul Klenerman; Sunetra Gupta; Craig P Thompson
Journal:  JCI Insight       Date:  2022-07-08

8.  SARS-CoV-2 Spike Protein Vaccine-Induced Immune Imprinting Reduces Nucleocapsid Protein Antibody Response in SARS-CoV-2 Infection.

Authors:  Juan F Delgado; Mónica Vidal-Pla; M Carmen Moya; Mateu Espasa; Antonio Casabella; Manel Seda; Joan Calvet; Jordi Gratacós; Rosa M Serrano; Pilar Peña
Journal:  J Immunol Res       Date:  2022-07-29       Impact factor: 4.493

9.  Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity.

Authors:  Julius Nückel; Elisa Planatscher; Anne Wiebe Mohr; Karolin Deichl; Hrvoje Mijočević; Martin Feuerherd; Lisa Wolff; Johanna Erber; Jochen Schneider; Michael Quante; Christoph Winter; Jürgen Ruland; Alexander Hapfelmeier; Wolfgang Hammerschmidt; Andreas Moosmann; Ulrike Protzer; Uta Behrends; Josef Mautner
Journal:  Front Immunol       Date:  2022-09-07       Impact factor: 8.786

10.  [Possible effect of the "original antigenic sin" in vaccination against new variants of SARS-CoV-2].

Authors:  J Reina
Journal:  Rev Clin Esp       Date:  2021-06-05       Impact factor: 1.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.